Department of Psychiatry
Penn Behavioral Health

HIV/AIDS Prevention Research Division

subpage feature

HVTN 906


About the study

We are doing this study to answer these questions:

  • Can we find and maintain contact with women at risk for HIV infection?
  • How likely are women at risk for HIV infection to become infected with HIV?

The US National Institutes of Health (NIH) is paying for this study. You do not have to pay to be in this study.

The study will take about 2 years and nine months to complete. You will be in the study for one year and a half, or 18 months.

About 800 women will take part in this study at three sites in the United States. About 300 women will be enrolled in the study at the Philadelphia site.

Before you can join this study, we will screen you to see if you are eligible. Screening involves a rapid HIV test and a urine pregnancy test. If you are eligible and agree to be in the study, we will schedule an enrollment visit with you. At this visit, you will complete questionnaires, answer questions. The enrollment visit will take about 1 hour. You will receive $25 in cash or check for your time and 2 Septa tokens for your travel for each of these visits.

At 6, 12 and 18 months after your enrollment visit, you will have follow-up visits. You will be tested for HIV, complete a pregnancy test, complete questionnaires, answer questions about your sexual and drug use behaviors and those of your partners, your use of contraceptives, and whether being in the study has caused you any problems. You will also receive HIV counseling.  You will receive the results of your HIV and pregnancy tests. Follow-up visits will take about 2 hours. You will receive $25 in cash or check for your time and 2 Septa tokens for your travel for each of these visits.

This is an observational study, meaning no one will receive experimental treatments or vaccines.

If you are interested in more information, please contact us at 1-866-HIV-PENN.


Protocol Title

HVTN 906: Longitudinal study of women at high risk for HIV-1 infection to inform HIV vaccine trial participation (Protocol version 1.0, August 12, 2008)


Principal Investigator

David S. Metzger, PhD
3535 Market St., 4th floor, Ste 4000
215-746-7346


Co-Investigators

Ian Frank, MD
3535 Market St., 4th floor, Ste 4000
215-662-7419

Debora Dunbar, MSN, CRNP
3535 Market St., 4th floor, Ste 4000
215-746-3713

 

Back to Current Studies

Connect with us twitter

Contact Us arrow

To make an appointment, or inquire further about our services, please call: 1-866-448-7366.

Click here for directions and contact information.